We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

28 hedge funds and large institutions have $19.2M invested in ALPS Medical Breakthroughs ETF in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

33% more call options, than puts

Call options by funds: $703K | Put options by funds: $530K

16% more capital invested

Capital invested by funds: $16.6M → $19.2M (+$2.62M)

8% more funds holding

Funds holding: 2628 (+2)

0.14% more ownership

Funds ownership: 14.55%14.69% (+0.14%)

Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.7%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
10
Reduced
7
Closed
3
Calls
$703K
Puts
$530K
Net Calls
+$173K
Net Calls Change
+$348K
Name Holding Trade Value Shares
Change
Change in
Stake
Simplex Trading
26
Simplex Trading
Illinois
$2K -$1.11K -38 -37%
AWM
27
AllSquare Wealth Management
New York
$2K
Envestnet Asset Management
28
Envestnet Asset Management
Illinois
$1K -$8.57K -292 -88%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
-$656K -22,343 Closed
Creative Planning
30
Creative Planning
Kansas
-$8K -300 Closed
CG
31
Cutler Group
California
-$88 -3 Closed

SBIO Hedge Fund Activity: Q3 2017 in Review

28 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q3 2017, worth a combined $19.2M — up 16% from $16.6M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new SBIO positions and 3 closed out — a net gain of 2 holders — while 10 added to existing stakes and 7 trimmed.

The largest buyer was Barometer Capital Management, opening a new position worth an estimated $2.47M. The largest seller was Wells Fargo, cutting an estimated $2.55M.

  • 28 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q3 2017, up from 26 in Q2 2017.
  • Funds reported $19.2M of ALPS Medical Breakthroughs ETF stock for Q3 2017, up 16% quarter-over-quarter.
  • 5 funds opened new ALPS Medical Breakthroughs ETF positions in Q3 2017 and 3 closed out, a net change of +2 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q3 2017 was Barometer Capital Management, an estimated $2.47M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q3 2017 was Wells Fargo, an estimated $2.55M sold.

Based on aggregated 13F filings for Q3 2017.